WallStSmart
CELC

Celcuity LLC

NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY

$119.00
-0.89% today

Updated 2026-04-29

Market cap
$5.80B
P/E ratio
P/S ratio
EPS (TTM)
$-3.79
Dividend yield
52W range
$10 – $129
Volume
0.7M

Celcuity LLC (CELC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$154000.00
Revenue growth (YoY)
Cost of revenue$58376.00$73059.00$104704.00$223037.00$338996.00$385591.00$303235.00$210918.00$142772.00$129947.00$167000.00
Gross profit$-58376.00$-73059.00$-104704.00$-223037.00$-338996.00$-385591.00$-303235.00$-210918.00$-142772.00$-129947.00$-167000.00
Gross margin-108.4%
R&D$2.01M$3.06M$4.98M$6.33M$6.27M$7.68M$25.76M$35.29M$60.59M$104.20M$145.00M
SG&A$250091.00$263664.00$972518.00$1.61M$1.54M$1.87M$2.60M$4.10M$5.64M$9.06M$27.20M
Operating income$-2.26M$-3.33M$-5.95M$-7.93M$-7.81M$-9.56M$-28.36M$-39.39M$-66.23M$-113.27M$-172.19M
Operating margin-111813.0%
EBITDA$-2.20M$-3.26M$-5.85M$-7.71M$-7.47M$-9.17M$-28.04M$-39.18M$-58.31M$-101.37M$-172.19M
EBITDA margin-111813.0%
EBIT$-2.26M$-3.33M$-5.95M$-7.93M$-7.81M$-9.56M$-28.34M$-39.39M$-58.45M$-101.50M$-172.36M
Interest expense$0.00$0.00$451664.00$111.00$159.00$120.00$1.26M$2.11M$5.33M$10.28M$17.15M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.26M$-3.31M$-6.25M$-7.48M$-7.36M$-9.47M$-29.61M$-40.37M$-63.78M$-111.78M$-177.04M
Net income growth (YoY)-46.4%-88.9%-19.7%+1.6%-28.7%-212.5%-36.4%-58.0%-75.3%-58.4%
Profit margin-114962.3%